Health Care & Life Sciences » Biotechnology | Kane Biotech Inc.

Kane Biotech Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
159.90
41.90
104.60
379.90
1,035.30
506.30
Cost of Goods Sold (COGS) incl. D&A
35.40
49.10
87.60
173.20
191.80
462.60
Gross Income
124.50
7.20
17.00
206.70
843.50
43.70
SG&A Expense
1,560.80
1,236.90
1,846.30
2,763.90
3,538.50
3,032
EBIT
1,436.30
1,244.10
1,829.30
-
2,695.00
2,988.30
Unusual Expense
58.70
312.80
69.30
-
-
335.70
Non Operating Income/Expense
40.80
36.60
289.70
119.60
16.40
143.10
Interest Expense
4.10
101.50
106.40
120.50
90.80
89.80
Pretax Income
1,447.40
1,614.90
1,710.00
2,548.70
2,786.20
3,261
Consolidated Net Income
1,447.40
1,614.90
1,710.00
2,548.70
2,786.20
3,261
Net Income
1,447.40
1,614.90
1,710.00
2,548.70
2,786.20
3,261
Net Income After Extraordinaries
1,447.40
1,614.90
1,710.00
2,548.70
2,786.20
3,261
Net Income Available to Common
1,447.40
1,614.90
1,710.00
2,548.70
2,786.20
3,261
EPS (Basic)
0.09
0.09
0.09
0.35
0.05
0.04
Basic Shares Outstanding
18,012.00
19,030.80
25,048.90
7,535.70
61,283.20
80,113.50
EPS (Diluted)
0.08
0.08
0.07
0.34
0.05
0.04
Diluted Shares Outstanding
18,012.00
19,030.80
25,048.90
7,535.70
61,283.20
80,113.50
EBITDA
1,400.80
1,204.90
1,786.70
2,508.20
2,625.60
2,916.50
Non-Operating Interest Income
10.90
6.90
5.20
9.40
15.90
9.60

About Kane Biotech

View Profile
Address
196 Innovation Drive
Winnipeg Manitoba R3T 2N2
Canada
Employees -
Website http://www.kanebiotech.com
Updated 07/08/2019
Kane Biotech, Inc. is a biotechnology company, which engages in the development and commercialization of products to prevent and remove biofilms. It uses a patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. Its trademarks include StrixNB, DispersinB, Aledex, blueste, AloSer, coactive, and Kane.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.